CANAKINUMAB TREATMENT IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), HIDS/MKD AND TRAPS: EFFICACY IN THE 16 WEEKS RANDOMISED CONTROLLED PHASE AND MAINTENANCE OF DISEASE CONTROL AND SAFETY AT WEEK 40

Author
Ozen, S.
De Benedetti, F.
Gattorno, M.
Frenkel, J.
Calvo, I.
Moutschen, M.
Quartier, P.
Anton, J.
Kone-Paut, I.
Lachmann, H.
Hoffman, H. M.
Ben-Chetrit, E.
Zeft, A.
Gong, Y.
Vritzali, E.
Junge, G.
Gul, A.
Kasapcopur, O.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/38902
https://doi.org/10.1136/annrheumdis-2017-eular.2194
Collections